Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Innovative Treatment of Scarred Vocal Folds
2020-004227-17Phase 2Active
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Jan 2021
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous adipose stromal vascular fraction in scarred vocal fold, sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoints: Primary: safety and tolerability and Primary: efficacy after injection. Started Jan 2021; status: active.
02
Drugs
autologous adipose stromal vascular fraction
03
Conditions
scarred vocal fold
Beyond the preview
Go deeper on 2020-004227-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004227-17.